Photo: Michael Ciaglo / Getty Images
The Vaccine Advisors at the Centers for Disease Control and Prevention (CDC) in the United States voted unanimously Thursday to recommend that people seeking vaccines or Safer and more effective reinforcements choose those from Pfizer-BioNTech or Moderna, rather than those made by Johnson & Johnson.
The experts recommended the use of the two mRNA vaccines due to an increased risk of problems with Potentially fatal blood clots associated with Johnson & Johnson injections.
According to official data, so far there have been nine deaths, between seven women and two men, aged between 28 and 62 years, among vaccinated with the dose of J&J Until September.
About 16 million people in the United States have received the Johnson & Johnson vaccine as primary immunization, compared to 73 million fully immunized with Moderna vaccine and 114,000,000 with Pfizer-BioNTech injections.
According to CNN, the CDC’s Advisory Committee on Immunization Practices also endorsed the updated recommendation after hearing new data indicating that a rare blood clotting syndrome could be more recurrent among people who recently received a J&J vaccine from what was previously believed.
The CDC has recorded 54 U.S. cases of thrombosis with thrombocytopenia syndrome or TTS since the vaccine was available. Nine people died: seven women and two men.
According to members of the Advisory Committee on Immunization Practices (ACIP), they considered the new data and compared it with numerous studies showing that J & J’s vaccine is less effective than Moderna and Pfizer / BioNTech vaccines in preventing infections.
Despite this, the CDC maintains that The known and potential benefits of the J&J vaccine outweigh the known and potential risks. Therefore, the Johnson & Johnson single-dose vaccine is licensed for use in individuals 18 years of age and older, and can be used as a booster vaccine for adults fully vaccinated with the J&J, Pfizer, or Moderna vaccines.
This recommendation comes days after the United States Food and Drug Administration (FDA) mentioned that only people with a history of a rare type of blood clotting should avoid receiving the Johnson & Johnson covid-19 vaccine.
The FDA clarified that it updated its vaccine fact sheets to warn people about the risk of thrombosis with thrombocytopenia syndrome (STT), a rare type of blood clotting event that has been linked to Johnson & Johnson vaccines.
Health Authorities Evaluate J&J Vaccine Restrictions in Fatal Blood Clots
What are the symptoms of the Omicron variant of the coronavirus?
Vaccination and precaution at Christmas time: the WHO’s call to prevent covid-19